Skip to content

Evorel Conti 3.2mg/11.2mg Transdermal Patches – 8 Patches | 24 Patches

Evorel Conti Patches are a prescription-only continuous combined hormone replacement therapy (HRT) containing estradiol (oestrogen) and norethisterone acetate (progestogen). These patches help relieve menopause symptoms, including hot flushes and night sweats, while the progestogen helps protect the lining of the womb. Applied twice weekly, Evorel Conti delivers both hormones gradually through the skin, providing a convenient alternative to daily HRT tablets.

Price range: £24.00 through £55.00

Clear

Your Health & Wellness Centre

Trusted pharmacy advice, tips and guides for all your healthcare needs

UK Pharmacist Prescribers

Safe & compliant prescribing

GPhC-Approved

UK-Registered Pharmacy

No GP Appointments Needed

Quick, hassle-free online consultation

Secure & Confidential

Your data is 100% protected

Fast & Discreet Delivery

Next-day UK delivery available

NHS Services

NHS Providing Service since 2020

Additional information

Quantity

24 Patches, 8 Patches

Description

Evorel Conti 3.2mg/11.2mg Transdermal Patches are a continuous combined hormone replacement therapy designed to help relieve symptoms associated with declining oestrogen levels after menopause.

During menopause, natural oestrogen production decreases, which can cause hot flushes, night sweats, sleep disturbances and other uncomfortable symptoms that affect daily life.

Evorel Conti contains two hormones:

  • Estradiol: An oestrogen that replaces declining natural hormone levels and helps relieve menopause symptoms.

  • Norethisterone acetate: A progestogen that helps protect the lining of the womb against excessive thickening caused by oestrogen treatment.

Each patch contains 3.2mg estradiol hemihydrate and 11.2mg norethisterone acetate, delivering approximately 50 micrograms of estradiol and 170 micrograms of norethisterone acetate every 24 hours.

Both hormones are released gradually through the skin, providing continuous hormone replacement without the need for daily tablets.

Evorel Conti is generally suitable for postmenopausal women who still have a womb and whose last natural menstrual period was at least 18 months ago. It is designed to provide continuous combined HRT without a regular monthly withdrawal bleed, although irregular bleeding or spotting may occur, particularly during the first few months.

Evorel Conti may also be prescribed to prevent osteoporosis in selected postmenopausal women at increased risk of fractures when other approved treatments are unsuitable.

Key Benefits

  • Helps relieve hot flushes and night sweats.

  • Replaces declining oestrogen levels after menopause.

  • Contains a progestogen to help protect the womb lining.

  • Provides continuous combined HRT through a single patch.

  • Convenient twice-weekly application.

  • Delivers hormones gradually through the skin.

  • Offers an alternative to oral HRT tablets.

  • Designed to avoid regular monthly withdrawal bleeding.

  • May help prevent osteoporosis in selected postmenopausal women.

  • Supplied as 8/24 patches, providing approximately four weeks of treatment.

Product Details

Detail Information
Product Name Evorel Conti
Brand Evorel
Manufacturer / Marketing Authorisation Holder Theramex
Active Ingredients Estradiol hemihydrate and norethisterone acetate
Strength per Patch 3.2mg / 11.2mg
Estradiol Delivery 50 micrograms per 24 hours
Norethisterone Acetate Delivery 170 micrograms per 24 hours
Form Transdermal patch
Pack Size 8/24 patches
Treatment Type Continuous combined HRT
Main Use Relief of postmenopausal symptoms
Administration Transdermal
Application Frequency Twice weekly
Pack Duration Approximately 4 weeks
Prescription Required Yes
Storage At or below 25°C

Directions

How to Apply Evorel Conti Patches

  1. Apply one patch twice weekly, changing it every three to four days.

  2. Choose a clean, dry, hairless area of skin below the waist, preferably the thigh or bottom.

  3. Open the protective sachet immediately before applying the patch.

  4. Peel away half of the protective backing without touching the adhesive surface.

  5. Apply the exposed adhesive side to the skin.

  6. Remove the remaining backing and press the entire patch firmly against the skin for at least 10 seconds.

  7. Leave the patch in place until your next scheduled change.

  8. Remove the old patch before applying a new one to a different area.

  9. Continue treatment without a break between packs.

Example Patch Schedule

Day Action
Monday Apply a new patch
Thursday Remove the old patch and apply a new one
Following Monday Replace the patch again

Important Application Advice

  • Never apply the patch on or near the breasts.

  • Avoid cuts, spots, irritated skin and areas beneath tight waistbands.

  • Do not apply moisturiser, talcum powder or lotion before applying.

  • Do not apply patches to exactly the same area consecutively.

  • You can usually shower, bathe and swim while wearing the patch.

  • Keep the patch covered during sunbathing.

  • Do not cut or alter the patch.

Side Effects

Like all medicines, Evorel Conti may cause side effects, although not everyone experiences them.

Very Common Side Effects

May affect more than 1 in 10 people:

– Redness, itching, irritation or a rash where the patch is applied.

Common Side Effects

May affect up to 1 in 10 people:

  • Headaches.

  • Breast pain or tenderness.

  • Nausea or abdominal discomfort.

  • Irregular vaginal bleeding or spotting.

  • Back pain.

  • Changes in mood.

  • Changes in body weight.

Uncommon Side Effects

May affect up to 1 in 100 people:

  • Vaginal infections, including thrush.

  • Reduced sexual desire.

  • Flatulence.

  • Itchy skin or rash.

  • Swelling of the hands or feet.

  • Muscle pain.

Other reported effects include dizziness, bloating, mood swings, gallstones and breast fullness.

Serious Side Effects and Risks

Combined HRT may increase the risk of certain conditions, including breast cancer, blood clots, stroke and heart disease. Individual risks depend on age, medical history and treatment duration.

Seek emergency medical attention if you experience:

  • Sudden chest pain or difficulty breathing.

  • Painful swelling or redness in one leg.

  • Sudden facial weakness, difficulty speaking or other stroke symptoms.

  • Swelling of the face, tongue or throat with breathing difficulties.

Remove the patch and seek urgent medical advice if you develop jaundice, a new migraine-type headache or a significant rise in blood pressure.

Warnings and Precautions

Do Not Use Evorel Conti If You:

  • Have, have previously had or are suspected of having breast cancer.

  • Have a known or suspected oestrogen-dependent cancer.

  • Have unexplained vaginal bleeding.

  • Have untreated endometrial hyperplasia.

  • Have or have previously had a blood clot.

  • Have certain inherited blood-clotting disorders.

  • Have experienced a heart attack, stroke or angina.

  • Have liver disease where liver function has not returned to normal.

  • Have porphyria.

  • Are allergic to estradiol, norethisterone acetate or another ingredient.

Consult Your Doctor Before Treatment If You Have:

  • Uterine fibroids or endometriosis.

  • High blood pressure or diabetes.

  • Migraines or severe headaches.

  • Gallstones or liver problems.

  • Epilepsy or asthma.

  • Heart or kidney conditions.

  • A family history of breast cancer.

  • An increased risk of blood clots.

  • Systemic lupus erythematosus.

  • High triglyceride levels.

  • Thyroid problems.

  • A history of endometrial hyperplasia.

Additional Safety Information

  • Evorel Conti is generally intended for women whose last natural menstrual period was at least 18 months ago.

  • It is not a contraceptive.

  • Do not use during pregnancy or breastfeeding.

  • Tell your doctor about all medicines and herbal supplements you take, including St John’s wort.

  • Some medicines used to treat epilepsy, tuberculosis and HIV may interfere with HRT.

  • Inform your doctor before planned surgery. Treatment may need to be stopped temporarily.

  • Attend regular HRT reviews and recommended breast screening.

  • Report unexpected vaginal bleeding that continues beyond six months, begins after six months or persists after stopping treatment.

  • Use the lowest effective dose for the shortest duration consistent with treatment goals and individual risks.

Ingredients

Active Ingredients

Each Evorel Conti patch contains:

  • Estradiol hemihydrate 3.2mg, equivalent to approximately 3.1mg estradiol.

  • Norethisterone acetate 11.2mg, equivalent to approximately 9.82mg norethisterone.

Each patch delivers approximately 50 micrograms of estradiol and 170 micrograms of norethisterone acetate every 24 hours.

Other Ingredients and Patch Materials

  • Acrylate-vinyl acetate copolymer adhesive (Duro-Tak 387-2287).

  • Guar gum.

  • Polyethylene terephthalate backing film (Hostaphan MN19).

  • Siliconised polyester protective release liner, removed before application.

Storage

  • Store at or below 25°C.

  • Keep patches in their original protective sachets and outer carton.

  • Keep out of the sight and reach of children.

  • Do not use if a protective sachet is already open.

  • Do not use after the expiry date printed on the packaging.

  • Fold used patches in half with the adhesive sides together.

  • Keep used patches away from children and pets, as they may still contain hormones.

  • Return unwanted or expired patches to a pharmacy for safe disposal.

Reviews

There are no reviews yet.

Be the first to review “Evorel Conti 3.2mg/11.2mg Transdermal Patches – 8 Patches | 24 Patches”

Your email address will not be published. Required fields are marked *

Verified customer reviews